Evidence map›Paper›PMID 41347528›Full record

ArticleEpidemiology and infection2025

Trends in asthma exacerbations in children before, during, and after the COVID-19 pandemic.

Liesa Stadhouders, Eline M Hoogteijling, Liesbeth Duijts, Ankie Lebon

Abstract read
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liesa StadhoudersDepartment of Pediatrics, Albert Schweitzer hospital, Dordrecht, The Netherlands.ORCID 0009-0005-3001-2357
Eline M HoogteijlingDepartment of Pediatrics, Albert Schweitzer hospital, Dordrecht, The Netherlands.
Liesbeth DuijtsDepartment of Pediatrics, division of Respiratory Medicine and Allergology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Ankie LebonDepartment of Pediatrics, Albert Schweitzer hospital, Dordrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory infections trigger asthma exacerbations. Despite being less severely affected by COVID-19 than adults, the subsequent lockdowns had a great impact on children. Previous studies showed a decrease in asthma exacerbations during the COVID-19 lockdowns, but findings from secondary care settings are scarce. We aimed to elucidate the trends in frequency and characteristics of asthma exacerbations in children presenting on an emergency department (ED) of a secondary care setting before, during, and after the COVID-19 pandemic. A retrospective analysis was conducted using data from ED visits between January 2018 and November 2022 for asthma exacerbations in children. The incidence of ED visits, hospital admissions, paediatric intensive care unit (PICU) admissions, administered medication, and demographic information were compared. A total of 1121 exacerbations were reported in 670 children, of whom 476 (42%) were admitted to hospital and 44 (3.9%) required PICU admission. We observed a decrease in ED visits for asthma exacerbations during the pandemic but an increased risk in hospital admissions and PICU transfers for exacerbations. This suggests a more severe course of exacerbations. Barriers to health care and lower viral exposure may contribute to this.

Indexed as

AsthmaCOVID-19AdolescentChildChild, PreschoolDisease ProgressionEmergency Service, HospitalFemaleHospitalizationHumansIncidenceInfantIntensive Care Units, PediatricMalePandemicsRetrospective Studiesallergyasthmabronchial hyperreactivityCOVID-19paediatric asthmaPICUsalbutamolviral wheezingwheezing

Identifiers

PMID41347528
PMCPMC12722538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.